deprenyl

(redirected from EMSAM)
Also found in: Medical, Wikipedia.

deprenyl

(ˈdɛprəˌnɪl)
n
a drug used to treat senile dementia, Parkinson's disease, Alzheimer's disease, and depression, by acting as a monoamine oxidase inhibitor
References in periodicals archive ?
With EMSAM, medication is absorbed over an extended period, which minimizes exposure to the digestive system, notes Bristol-Myers Squibb spokesman Craig Stoltz (Bristol-Myers Squibb and Somerset Pharmaceuticals developed EMSAM).
EMSAM incorporates selegiline into a pressure sensitive adhesive formulation for the transdermal delivery of therapeutically effective amounts of the drug.
With over 2,000 depressed patients exposed to EMSAM, we are encouraged by the product's safety data and view EMSAM as an important advance in the treatment of depression.